Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.

Cardiac abnormalities, cardiomyopathy and skeletal muscle weakness have been described in female carriers of the Xp21 (Duchenne and Becker) muscular dystrophies (J Neurol 1975;209(4):279-285; Br Med J 1969;2:418-420; J AmMed Assoc 1996;275(17):1335-1338; Neurology 1980;30(5):497-501; Neuromusc Disor...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Grain, L, Cortina-Borja, M, Forfar, C, Hilton-Jones, D, Hopkin, J, Burch, M
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 2001
_version_ 1826290766672035840
author Grain, L
Cortina-Borja, M
Forfar, C
Hilton-Jones, D
Hopkin, J
Burch, M
author_facet Grain, L
Cortina-Borja, M
Forfar, C
Hilton-Jones, D
Hopkin, J
Burch, M
author_sort Grain, L
collection OXFORD
description Cardiac abnormalities, cardiomyopathy and skeletal muscle weakness have been described in female carriers of the Xp21 (Duchenne and Becker) muscular dystrophies (J Neurol 1975;209(4):279-285; Br Med J 1969;2:418-420; J AmMed Assoc 1996;275(17):1335-1338; Neurology 1980;30(5):497-501; Neuromusc Disord 1999;9:347-351; Arch Neurol 1989;46:673-675). We have screened volunteers from our Xp21 genetics register and found the prevalence of previously unrecognized, clinically relevant, abnormalities in this group to be less than previously reported. We studied 91 women (56 carriers and 35 controls), aged between 18 and 69 years, from our local population known to the Oxford Regional Genetics Register. Our study included controls, with the investigators being blind to the subject's genetic status. The prevalence of previously unrecognised cardiac abnormalities on echocardiogram and ECG was 18% (10/56). Seven percent (4/56) of carriers had cardiomyopathy, defined by significant LV dilatation and decreased shortening fraction. In most cases, subjects with abnormal cardiac findings were asymptomatic. Echocardiography was more frequently abnormal than electrocardiography, but in many subjects the measurements of left ventricular dimensions were only just outside the normal ranges. The prevalence of skeletal muscle weakness was 12% (7/56). It was usually recognized by the individual, although not previously volunteered, but was mild and did not substantially affect activities of daily living.
first_indexed 2024-03-07T02:49:13Z
format Journal article
id oxford-uuid:ad16b56e-8d7c-4839-b2cc-7eb1db62cffc
institution University of Oxford
language English
last_indexed 2024-03-07T02:49:13Z
publishDate 2001
record_format dspace
spelling oxford-uuid:ad16b56e-8d7c-4839-b2cc-7eb1db62cffc2022-03-27T03:33:13ZCardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ad16b56e-8d7c-4839-b2cc-7eb1db62cffcEnglishSymplectic Elements at Oxford2001Grain, LCortina-Borja, MForfar, CHilton-Jones, DHopkin, JBurch, MCardiac abnormalities, cardiomyopathy and skeletal muscle weakness have been described in female carriers of the Xp21 (Duchenne and Becker) muscular dystrophies (J Neurol 1975;209(4):279-285; Br Med J 1969;2:418-420; J AmMed Assoc 1996;275(17):1335-1338; Neurology 1980;30(5):497-501; Neuromusc Disord 1999;9:347-351; Arch Neurol 1989;46:673-675). We have screened volunteers from our Xp21 genetics register and found the prevalence of previously unrecognized, clinically relevant, abnormalities in this group to be less than previously reported. We studied 91 women (56 carriers and 35 controls), aged between 18 and 69 years, from our local population known to the Oxford Regional Genetics Register. Our study included controls, with the investigators being blind to the subject's genetic status. The prevalence of previously unrecognised cardiac abnormalities on echocardiogram and ECG was 18% (10/56). Seven percent (4/56) of carriers had cardiomyopathy, defined by significant LV dilatation and decreased shortening fraction. In most cases, subjects with abnormal cardiac findings were asymptomatic. Echocardiography was more frequently abnormal than electrocardiography, but in many subjects the measurements of left ventricular dimensions were only just outside the normal ranges. The prevalence of skeletal muscle weakness was 12% (7/56). It was usually recognized by the individual, although not previously volunteered, but was mild and did not substantially affect activities of daily living.
spellingShingle Grain, L
Cortina-Borja, M
Forfar, C
Hilton-Jones, D
Hopkin, J
Burch, M
Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
title Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
title_full Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
title_fullStr Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
title_full_unstemmed Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
title_short Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls.
title_sort cardiac abnormalities and skeletal muscle weakness in carriers of duchenne and becker muscular dystrophies and controls
work_keys_str_mv AT grainl cardiacabnormalitiesandskeletalmuscleweaknessincarriersofduchenneandbeckermusculardystrophiesandcontrols
AT cortinaborjam cardiacabnormalitiesandskeletalmuscleweaknessincarriersofduchenneandbeckermusculardystrophiesandcontrols
AT forfarc cardiacabnormalitiesandskeletalmuscleweaknessincarriersofduchenneandbeckermusculardystrophiesandcontrols
AT hiltonjonesd cardiacabnormalitiesandskeletalmuscleweaknessincarriersofduchenneandbeckermusculardystrophiesandcontrols
AT hopkinj cardiacabnormalitiesandskeletalmuscleweaknessincarriersofduchenneandbeckermusculardystrophiesandcontrols
AT burchm cardiacabnormalitiesandskeletalmuscleweaknessincarriersofduchenneandbeckermusculardystrophiesandcontrols